Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.067 | 0.7 |
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |